ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹92 Cr | ₹87 Cr | ₹121 Cr | ₹115 Cr | ₹106 Cr |
What is the latest Contingent Liabilities ratio of ABBOTT INDIA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹92 Cr |
Mar2023 | ₹87 Cr |
Mar2022 | ₹121 Cr |
Mar2021 | ₹115 Cr |
Mar2020 | ₹106 Cr |
How is Contingent Liabilities of ABBOTT INDIA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹92 Cr | 5.17 | |
Mar2023 | ₹87 Cr | -28.00 | |
Mar2022 | ₹121 Cr | 5.32 | |
Mar2021 | ₹115 Cr | 8.35 | |
Mar2020 | ₹106 Cr | - |
Compare Contingent Liabilities of peers of ABBOTT INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ABBOTT INDIA | ₹60,524.1 Cr | -4.7% | -0.6% | 18.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
ABBOTT INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | -4.7% |
-0.6% |
18.8% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses